Selective dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors)

References

Citations

1. U.S. Food and Drug Administration (2006). FDA approves new treatment for diabetes. FDA News P06-169. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01492.html.

2. Sitagliptin/metformin (Janumet) for type 2 diabetes (2007). Medical Letter on Drugs and Therapeutics, 49(1262): 45–47.

3. Sitagliptin (Januvia) section of Investigational drugs (2006, August). In RM Wickersham et al., eds., Drug Facts and Comparisons, pp. KU-109. St. Louis: Wolters Kluwer Health.

Author:	Caroline Rea, RN, BS, MS	Last Updated: August 14, 2007
Medical Review:	Caroline S. Rhoads, MD - Internal Medicine Matthew I. Kim, MD - Endocrinology & Metabolism
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.